Redburn Slaps McDonald’s With Rare Downgrade As GLP-1 Drugs Reshape Consumer Habits As we’ve previously noted, the shift toward “better-for-you” consumption is well underway, whether fueled by the “Make America Healthy Again” (MAHA) movement or the increasing adoption of miracle weight-loss drugs suppressing appetites. Either way, the inflection point for U.S. restaurants has arrived. Redburn Atlantic analyst Edward Lewis became the first in recent memory to downgrade McDonald’s, cutting the stock from “Buy” to “Sell” on the premise that GLP-1 weight-loss drugs will suppress consumer appetites. Lewis now stands alone among the 41 analysts tracked by Bloomberg with a bearish stance on… — Continue at ZeroHedge News : Read More
